SENNA-S- docusate sodium, sennosides tablet, film coated

Senna-S by

Drug Labeling and Warnings

Senna-S by is a Otc medication manufactured, distributed, or labeled by Granulation Technology, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredients (in each tablet)

Docusate Sodium         50 mg

Sennosides                       8.6 mg

Purpose

Stool softener

Laxative

Uses

• Relieves occasional constipation (irregularity)
• Generally produces a bowel movement in 6-12 hours

Warnings

Do not use

• If you are now taking mineral oil, unless directed by a doctor
• Laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

• Stomach pain
• Nausea
• Vomiting
• Noticed a sudden change in bowel habits that continues over a period of two weeks

Stop using and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

• Take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children; 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

• Each tablet contains: Calcium 30 mg, Sodium 6 mg LOW SODIUM
• Store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol (PEG) 3350, talc, FD&C red 40 lake, FD&C yellow 5 lake

Principal Display Panel

NDC: 63561-0187-01

Senna-S

DOCUSATE SODIUM 50 mg / STOOL SOFTENER

SENNOSIDES 8.6 mg / LAXATIVE

Compare to Senokot-S ®Dual Action Active Ingredients

100 Film-Coated Tablets

NDC: 63561-0187-02

Senna-S

DOCUSATE SODIUM 50 mg / STOOL SOFTENER

SENNOSIDES 8.6 mg / LAXATIVE

Compare to Senokot-S ®Dual Action Active Ingredients

220 Film-Coated Tablets

NDC: 63561-0187-03

Senna-S

DOCUSATE SODIUM 50 mg / STOOL SOFTENER

SENNOSIDES 8.6 mg / LAXATIVE

Compare to Senokot-S ®Dual Action Active Ingredients

1000 Film-Coated Tablets

INGREDIENTS AND APPEARANCE

SENNA-S 
docusate sodium, sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 63561-0187
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg

Inactive Ingredients
Ingredient Name	Strength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
MICROCRYSTALLINE CELLULOSE 200 (UNII: 5XDI2TS1EZ)
STARCH, CORN (UNII: O8232NY3SJ)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)
POLYVINYL ALCOHOL (UNII: 532B59J990)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
TALC (UNII: 7SEV7J4R1U)
FD&C RED NO. 40 ALUMINUM LAKE (UNII: 6T47AS764T)
FD&C YELLOW NO. 5 ALUMINUM LAKE (UNII: JQ6BLH9FR7)

Product Characteristics
Color	orange	Score	no score
Shape	ROUND	Size	10mm
Flavor		Imprint Code	G187
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 63561-0187-2	220 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	07/29/2025
2	NDC: 63561-0187-1	100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	07/29/2025
3	NDC: 63561-0187-3	1000 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	07/29/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	07/29/2025

Labeler - Granulation Technology, Inc. (847132193)

Registrant - Granulation Technology, Inc. (847132193)

Establishment
Name	Address	ID/FEI	Business Operations
Granulation Technology, Inc.		847132193	manufacture(63561-0187)